Alain Alsalhani
Biographic Data
| ID | 1840447 |
|---|---|
| NAME | Alain Alsalhani |
| GIVEN NAMES | Alain |
| FAMILY NAME | Alsalhani |
| SIGNATURE | ALSALHANI A |
| AFFILIATIONS | Médecins Sans Frontières |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Mpox exposes fundamental obstacles for vaccinating children in outbreaks
box Children could not be included in mpox vaccination roll-out within the first 100 days of the latest Mpox outbreak in the Democratic Republic of Congo and are yet to be rolled out in many countries with rising cases, despite this age group accounting for a large proportion of suspected cases and deaths
Recently developed drugs for the treatment of drug-resistant tuberculosis
Two drugs with novel mechanisms of action, the diarylquinoline bedaquiline and the nitroimidazole delamanid—as well as pretomanid from the same class of drugs as delamanid—have recently become available to treat drug-resistant tuberculosis (DR-TB) after many decades of little innovation in the field of DR-TB treatment. Despite evidence of improved efficacy and reduced toxicity of multidrug regimens including the two agents, access to bedaquiline …
Developing countries can make the mRNA vaccines they need
No prominent works on this page.
Recently developed drugs for the treatment of drug-resistant tuberculosis
Two drugs with novel mechanisms of action, the diarylquinoline bedaquiline and the nitroimidazole delamanid—as well as pretomanid from the same class of drugs as delamanid—have recently become available to treat drug-resistant tuberculosis (DR-TB) after many decades of little innovation in the field of DR-TB treatment. Despite evidence of improved efficacy and reduced toxicity of multidrug regimens including the two agents, access to bedaquiline …
Developing countries can make the mRNA vaccines they need
Mpox exposes fundamental obstacles for vaccinating children in outbreaks
box Children could not be included in mpox vaccination roll-out within the first 100 days of the latest Mpox outbreak in the Democratic Republic of Congo and are yet to be rolled out in many countries with rising cases, despite this age group accounting for a large proportion of suspected cases and deaths
Medicine (2 works) · Virology (2 works) · Bacillus and Francisella bacterial research (1 work) · Bedaquiline (1 work) · Biology (1 work) · Business (1 work) · Clinical trial (1 work) · Computational biology (1 work) · Computer Science (1 work) · Developing country (1 work)